Current Problems in Surgery
Volume 44, Issue 7 , Pages 396-482 , July 2007

Cancer of the Gallbladder and Extrahepatic Bile Ducts

  • Sean P. Cleary, MD

      Affiliations

    • Fellow in Pancreatic and Hepatobiliary Surgical Oncology and Transplantation, Department of Surgery, University Health Network–Toronto General Hospital, Toronto, Ontario, Canada
    • ,
  • Laura A. Dawson, MD

      Affiliations

    • Associate Professor of Radiation Oncology, University Health Network–Princess Margaret Hospital, Toronto, Ontario, Canada
    • ,
  • Jennifer J. Knox, MD

      Affiliations

    • Assistant Professor of Medicine, Department of Medical Oncology, University Health Network–Princess Margaret Hospital, Toronto, Ontario, Canada
    • ,
  • Steven Gallinger, MD

      Affiliations

    • Professor of Surgery, University Health Network–Toronto General Hospital, Toronto, Ontario, Canada

References 

  1. Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology. 2004;66:167–179
  2. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis (An unusual tumour with distinctive clinical and pathological features). Am J Med. 1965;38:241–256
  3. Yeo C, Cameron J. Tumours of the gallbladder and bile ducts. In:  Zinner MJ editors. Maingot’s Abdominal Operations. New York: McGraw-Hill; 1997;p. 1835–1854
  4. Adson MA. Carcinoma of the gallbladder. Surg Clin North Am. 1973;53:1203–1216
  5. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma (A spectrum of intrahepatic, perihilar, and distal tumors). Ann Surg. 1996;224:463–473discussion 473-5
  6. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130
  7. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591–1602
  8. Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004;4:695–706
  9. Serra I, Diehl AK. Number and size of stones in patients with asymptomatic and symptomatic gallstones and gallbladder carcinoma. [comment] J Gastrointest Surg. 2002;6:272–273author reply 273
  10. Perpetuo MD, Valdivieso M, Heilbrun LK, et al. Natural history study of gallbladder cancer: a review of 36 years experience at M. D. Anderson Hospital and Tumor Institute. Cancer. 1978;42:330–335
  11. Dutta U, Nagi B, Garg PK, et al. Patients with gallstones develop gallbladder cancer at an earlier age. Eur J Cancer Prev. 2005;14:381–385
  12. Lowenfels AB, Lindstrom CG, Conway MJ, Hastings PR. Gallstones and risk of gallbladder cancer. J Natl Cancer Inst. 1985;75:77–80
  13. Diehl AK. Epidemiology of gallbladder cancer: a synthesis of recent data. J Natl Cancer Inst. 1980;65:1209–1214
  14. Zatonski WA, Lowenfels AB, Boyle P, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst. 1997;89:1132–1138
  15. Lowenfels AB, Walker AM, Althaus DP, et al. Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol. 1989;18:50–54
  16. Diehl AK. Gallstone size and the risk of gallbladder cancer. JAMA. 1983;250:2323–2326
  17. Strom BL, Soloway RD, Rios-Dalenz JL, et al. Risk factors for gallbladder cancer (An international collaborative case-control study). [see comment] Cancer. 1995;76:1747–1756
  18. Hemminki K, Li X. Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden. Gut. 2003;52:592–596
  19. Pandey M, Shukla VK. Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer. Eur J Cancer Prev. 2003;12:269–272
  20. Rajagopalan V, Daines WP, Grossbard ML, Kozuch P. Gallbladder and biliary tract carcinoma: a comprehensive update, part 1. Oncology (Huntington). 2004;18:889–896
  21. Stephen AE, Berger DL. Carcinoma in the porcelain gallbladder: a relationship revisited. Surgery. 2001;129:699–703
  22. Koga A, Watanabe K, Fukuyama T, et al. Diagnosis and operative indications for polypoid lesions of the gallbladder. Arch Surg. 1988;123:26–29
  23. Aldridge MC, Bismuth H. Gallbladder cancer: the polyp-cancer sequence. Br J Surg. 1990;77:363–364
  24. Combined oral contraceptives and gallbladder cancer (The WHO Collaborative Study of Neoplasia and Steroid Contraceptives). Anonymous Int J Epidemiol. 1989;18:309–314
  25. Moerman CJ, Bueno de Mesquita HB, Runia S. Smoking, alcohol consumption and the risk of cancer of the biliary tract; a population-based case-control study in The Netherlands. Eur J Cancer Prev. 1994;3:427–436
  26. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. [see comment] N Engl J Med. 2003;348:1625–1638
  27. Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer. 1994;30A:344–350
  28. Serra I, Yamamoto M, Calvo A, et al. Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int J Cancer. 2002;102:407–411[Erratum appears in Int J Cancer. 2003;104:798.]
  29. Dutta U, Garg PK, Kumar R, Tandon RK. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. [see comment] Am J Gastroenterol. 2000;95:784–787
  30. Shukla VK, Singh H, Pandey M, et al. Carcinoma of the gallbladder–is it a sequel of typhoid?. Dig Dis Sci. 2000;45:900–903
  31. Nath G, Singh H, Shukla VK. Chronic typhoid carriage and carcinoma of the gallbladder. Eur J Cancer Prev. 1997;6:557–559
  32. Bulajic M, Maisonneuve P, Schneider-Brachert W, et al. Helicobacter pylori and the risk of benign and malignant biliary tract disease. [see comment] Cancer. 2002;95:1946–1953
  33. Kimura K, Ohto M, Saisho H, et al. Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union. Gastroenterology. 1985;89:1258–1265
  34. Nuzzo G, Clemente G, Cadeddu F, et al. Papillary carcinoma of the gallbladder and anomalous pancreatico-biliary junction (Report of three cases and review of the literature). Hepatogastroenterology. 2005;52:1034–1038
  35. Diehl AK, Beral V. Cholecystectomy and changing mortality from gallbladder cancer. Lancet. 1981;2:187–189
  36. Diehl AK. Changing cholecystectomy rates since the introduction of laparoscopic cholecystectomy. Am J Gastroenterol. 1996;91:2653–2654
  37. Wood R, Fraser LA, Brewster DH, Garden OJ. Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968-1998. Eur J Cancer. 2003;39:2080–2086
  38. Levi F, Lucchini F, Negri E, La Vecchia C. The recent decline in gallbladder cancer mortality in Europe. Eur J Cancer Prev. 2003;12:265–267
  39. Chianale J, del Pino G, Nervi F. Increasing gall-bladder cancer mortality rate during the last decade in Chile, a high-risk area. Int J Cancer. 1990;46:1131–1133
  40. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet. 2005;366:1303–1314
  41. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24:115–125
  42. Strom BL, Hibberd PL, Soper KA, et al. International variations in epidemiology of cancers of the extrahepatic biliary tract. Cancer Res. 1985;45:5165–5168
  43. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer. 1995;75(1 Suppl):171–190
  44. Burak K, Angulo P, Pasha TM, et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol. 2004;99:523–526
  45. Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996;38:610–615
  46. Bergquist A, Glaumann H, Persson B, Broome U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology. 1998;27:311–316
  47. Chalasani N, Baluyut A, Ismail A, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. [see comment] Hepatology. 2000;31:7–11
  48. Watanapa P, Watanapa WB. Liver fluke-associated cholangiocarcinoma. Br J Surg. 2002;89:962–970
  49. Chaimuangraj S, Thamavit W, Tsuda H, Moore MA. Experimental investigation of opisthorchiasis-associated cholangiocarcinoma induction in the Syrian hamster—pointers for control of the human disease. Asian Pac J Cancer Prev. 2003;4:87–93
  50. Thamavit W, Bhamarapravati N, Sahaphong S, et al. Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res. 1978;38(12):4634–4639
  51. Lipsett PA, Pitt HA, Colombani PM, et al. Choledochal cyst disease (A changing pattern of presentation). Ann Surg. 1994;220:644–652
  52. Chijiiwa K, Koga A. Surgical management and long-term follow-up of patients with choledochal cysts. Am J Surg. 1993;165:238–242
  53. Lipshutz GS, Brennan TV, Warren RS. Thorotrast-induced liver neoplasia: a collective review. J Am Coll Surg. 2002;195:713–718
  54. Wistuba II, Tang M, Maitra A, et al. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma. Cancer Res. 2001;61:3795–3800
  55. Wistuba II, Maitra A, Carrasco R, et al. High resolution chromosome 3p, 8p, 9q and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma. Br J Cancer. 2002;87:432–440
  56. Hidaka E, Yanagisawa A, Sakai Y, et al. Losses of heterozygosity on chromosomes 17p and 9p/18q may play important roles in early and advanced phases of gallbladder carcinogenesis. J Cancer Res Clin Oncol. 1999;125(8-9):439–443
  57. Saetta A, Koilakou SV, Michalopoulos NV, Davaris PS. Evaluation of BAT-26 as an indicator of microsatellite instability in gallbladder carcinomas. Hepatogastroenterology. 2003;50:1799–1802
  58. Takahashi T, Shivapurkar N, Riquelme E, et al. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis. Clin Cancer Res. 2004;10(18 Pt 1):6126–6133
  59. Sirica AE. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology. 2005;41:5–15
  60. Ahrendt SA, Eisenberger CF, Yip L, et al. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma. J Surg Res. 1999;84:88–93
  61. Berthiaume EP, Wands J. The molecular pathogenesis of cholangiocarcinoma. Semin Liver Dis. 2004;24:127–137
  62. Jaiswal M, LaRusso NF, Shapiro RA, et al. Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology. 2001;120:190–199
  63. Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res. 2000;60:184–190
  64. Torok NJ, Higuchi H, Bronk S, Gores GJ. Nitric oxide inhibits apoptosis downstream of cytochrome C release by nitrosylating caspase 9. Cancer Res. 2002;62:1648–1653
  65. Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell. 2002;110:669–672
  66. Hayashi N, Yamamoto H, Hiraoka N, et al. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. Hepatology. 2001;34(4 Pt 1):638–650
  67. Cancer risks in BRCA2 mutation carriers (The Breast Cancer Linkage Consortium). J Natl Cancer Inst. 1999;91:1310-6
  68. Sturm PD, Baas IO, Clement MJ, et al. Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area. Int J Cancer. 1998;78:695–698
  69. Albores-Saavedra J, Alcantra-Vazquez A, Cruz-Ortiz H, Herrera-Goepfert R. The precursor lesions of invasive gallbladder carcinoma (Hyperplasia, atypical hyperplasia and carcinoma in situ). Cancer. 1980;45:919–927
  70. Kozuka S, Tsubone N, Yasui A, Hachisuka K. Relation of adenoma to carcinoma in the gallbladder. Cancer. 1982;50:2226–2234
  71. Wistuba II, Miquel JF, Gazdar AF, Albores-Saavedra J. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Hum Pathol. 1999;30:21–25
  72. Kijima H, Watanabe H, Iwafuchi M, Ishihara N. Histogenesis of gallbladder carcinoma from investigation of early carcinoma and microcarcinoma. Acta Pathologica Japonica. 1989;39:235–244
  73. Takei K, Watanabe H, Itoi T, Saito T. p53 and Ki-67 immunoreactivity and nuclear morphometry of “carcinoma-in-adenoma” and adenoma of the gall-bladder. Pathol Int. 1996;46:908–917[Republished from Pathol Int. 1996;46:426-35; PMID: 8869994.]
  74. Watanabe H, Date K, Itoi T, et al. Histological and genetic changes in malignant transformation of gallbladder adenoma. Ann Oncol. 1999;10(Suppl 4):136–139
  75. Schlemper RJ, Kato Y, Stolte M. Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol. 2001;36:445–456
  76. Sasatomi E, Tokunaga O, Miyazaki K. Precancerous conditions of gallbladder carcinoma: overview of histopathologic characteristics and molecular genetic findings. J Hepatobiliary Pancreat Surg. 2000;7:556–567
  77. Nakajo S, Yamamoto M, Tahara E. Morphometrical analysis of gall-bladder adenoma and adenocarcinoma with reference to histogenesis and adenoma-carcinoma sequence. Virchows Arch. 1990;417:49–56
  78. Yamaguchi K, Enjoji M. Carcinoma of the gallbladder (A clinicopathology of 103 patients and a newly proposed staging). Cancer. 1988;62:1425–1432
  79. Roa I, de Aretxabala X, Araya JC, Roa J. Preneoplastic lesions in gallbladder cancer. J Surg Oncol. 2006;93:615–623
  80. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the gallbladder (Histologic types, stage of disease, grade, and survival rates). Cancer. 1992;70:1493–1497
  81. Albores-Saavedra J, Tuck M, McLaren BK, et al. Papillary carcinomas of the gallbladder: analysis of noninvasive and invasive types. Arch Pathol Lab Med. 2005;129:905–909
  82. Vardaman C, Albores-Saavedra J. Clear cell carcinomas of the gallbladder and extrahepatic bile ducts. Am J Surg Pathol. 1995;19:91–99
  83. Levy AD, Murakata LA, Rohrmann CA. Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics. 2001;21:295–314questionnaire. [Erratum appears in Radiographics. 2001;21:766.]
  84. Sumiyoshi K, Nagai E, Chijiiwa K, Nakayama F. Pathology of carcinoma of the gallbladder. World J Surg. 1991;15:315–321
  85. Fahim RB, Mc DJ, Richards JC, Ferris DO. Carcinoma of the gallbladder: a study of its modes of spread. Ann Surg. 1962;156:114–124
  86. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. [see comment] Lancet Oncol. 2003;4:167–176
  87. Rossi RL, Silverman ML, Braasch JW, et al. Carcinomas arising in cystic conditions of the bile ducts (A clinical and pathologic study). Ann Surg. 1987;205:377–384
  88. Weinbren K, Mutum SS. Pathological aspects of cholangiocarcinoma. J Pathol. 1983;139:217–238
  89. Lim JH, Yoon KH, Kim SH, et al. Intraductal papillary mucinous tumor of the bile ducts. Radiographics. 2004;24:53–66discussion 66-7
  90. Lim JH, Kim MH, Kim TK, et al. Papillary neoplasms of the bile duct that mimic biliary stone disease. Radiographics. 2003;23:447–455
  91. Choi BI, Lee JM, Han JK. Imaging of intrahepatic and hilar cholangiocarcinoma. Abdom Imaging. 2004;29:548–557
  92. Abdalla EK, Vauthey JN, Couinaud C. The caudate lobe of the liver: implications of embryology and anatomy for surgery. Surg Oncol Clin N Am. 2002;11:835–848
  93. Blumgart LH, Hann LE. Surgical and radiologic anatomy of the liver and biliary tract. In:  Blumgart LH,  Fong Y editor. Surgery of the Liver and Biliary Tract. Vol. 1:Edinburgh WB: Saunders; 2003;p. 3–33
  94. Tsao JI, Nimura Y, Kamiya J, et al. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg. 2000;232:166–174
  95. Ouchi K, Owada Y, Matsuno S, Sato T. Prognostic factors in the surgical treatment of gallbladder carcinoma. Surgery. 1987;101:731–737
  96. Liu KJ, Richter HM, Cho MJ, et al. Carcinoma involving the gallbladder in elderly patients presenting with acute cholecystitis. Surgery. 1997;122:748–754discussion 754-6
  97. Redaelli CA, Buchler MW, Schilling MK, et al. High coincidence of Mirizzi syndrome and gallbladder carcinoma. [see comment] Surgery. 1997;121:58–63
  98. Strom BL, Maislin G, West SL, et al. Serum CEA and CA 19-9: potential future diagnostic or screening tests for gallbladder cancer?. Int J Cancer. 1990;45:821–824
  99. Ritts RE, Nagorney DM, Jacobsen DJ, et al. Comparison of preoperative serum CA19-9 levels with results of diagnostic imaging modalities in patients undergoing laparotomy for suspected pancreatic or gallbladder disease. Pancreas. 1994;9:707–716
  100. Jarnagin WR, Shoup M. Surgical management of cholangiocarcinoma. Semin Liver Dis. 2004;24:189–199
  101. Wibbenmeyer LA, Sharafuddin MJ, Wolverson MK, et al. Sonographic diagnosis of unsuspected gallbladder cancer: imaging findings in comparison with benign gallbladder conditions. AJR Am J Roentgenol. 1995;165:1169–1174
  102. Pandey M, Sood BP, Shukla RC, et al. Carcinoma of the gallbladder: role of sonography in diagnosis and staging. J Clin Ultrasound. 2000;28:227–232
  103. Chijiiwa K, Sumiyoshi K, Nakayama F. Impact of recent advances in hepatobiliary imaging techniques on the preoperative diagnosis of carcinoma of the gallbladder. World J Surg. 1991;15:322–327
  104. Bach AM, Loring LA, Hann LE, et al. Gallbladder cancer: can ultrasonography evaluate extent of disease?. J Ultrasound Med. 1998;17:303–309
  105. Ohtani T, Shirai Y, Tsukada K, et al. Spread of gallbladder carcinoma: CT evaluation with pathologic correlation. Abdom Imaging. 1996;21:195–201
  106. Yoshimitsu K, Honda H, Shinozaki K, et al. Helical CT of the local spread of carcinoma of the gallbladder: evaluation according to the TNM system in patients who underwent surgical resection. AJR Am J Roentgenol. 2002;179:423–428
  107. Smathers RL, Lee JK, Heiken JP. Differentiation of complicated cholecystitis from gallbladder carcinoma by computed tomography. AJR Am J Roentgenol. 1984;143:255–259
  108. Ohtani T, Shirai Y, Tsukada K, et al. Carcinoma of the gallbladder: CT evaluation of lymphatic spread. Radiology. 1993;189:875–880
  109. Koh T, Taniguchi H, Yamaguchi A, et al. Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluoro-deoxyglucose (FDG-PET). J Surg Oncol. 2003;84:74–81
  110. Anderson CD, Rice MH, Pinson CW, et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg. 2004;8:90–97
  111. Rodriguez-Fernandez A, Gomez-Rio M, Medina-Benitez A, et al. Application of modern imaging methods in diagnosis of gallbladder cancer. J Surg Oncol. 2006;93:650–664
  112. Rosenbaum SJ, Stergar H, Antoch G, et al. Staging and follow-up of gastrointestinal tumors with PET/CT. Abdom Imaging. 2006;31:25–35
  113. Petrowsky H, Wildbrett P, Husarik DB, et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol. 2006;45:43–50
  114. Bach AM, Hann LE, Brown KT, et al. Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology. 1996;201:149–154
  115. Hann LE, Fong Y, Shriver CD, et al. Malignant hepatic hilar tumors: can ultrasonography be used as an alternative to angiography with CT arterial portography for determination of resectability?. J Ultrasound Med. 1996;15:37–45
  116. Brugge WR. Endoscopic techniques to diagnose and manage biliary tumors. J Clin Oncol. 2005;23:4561–4565
  117. Manfredi R, Barbaro B, Masselli G, et al. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis. 2004;24:155–164
  118. Zidi SH, Prat F, Le Guen O, et al. Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures. Gut. 2000;46:103–106
  119. Kluge R, Schmidt F, Caca K, et al. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology. 2001;33:1029–1035
  120. Keiding S, Hansen SB, Rasmussen HH, et al. [Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography]. Ugeskr Laeger. 2000;162:782–785
  121. Gores GJ. Early detection and treatment of cholangiocarcinoma. [see comment] Liver Transplant. 2000;6(6 Suppl 2):S30–S34
  122. Nevin JE, Moran TJ, Kay S, King R. Carcinoma of the gallbladder: staging, treatment, and prognosis. Cancer. 1976;37:141–148
  123. Fleming ID, Cooper JS, Henderson DE. AJCC Cancer Staging Manual. 5th ed.. New York: Springer; 1997;
  124. Greene FL, Page DL, Fleming ID. AJCC Cancer Staging Manual. 6th ed.. New York: Springer; 2002;
  125. Fong Y, Wagman L, Gonen M, et al. Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann Surg. 2006;243:767–771discussion 771-4
  126. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975;140:170–178
  127. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507–517discussion 517-9
  128. Hemming AW, Reed AI, Fujita S, et al. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241:693–699discussion 699-702
  129. Piehler JM, Crichlow RW. Primary carcinoma of the gallbladder. Surg Gynecol Obstet. 1978;147:929–942
  130. Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinomas of the gallbladder (Results of the French Surgical Association Survey). Ann Surg. 1994;219:275–280
  131. Wilkinson DS. Carcinoma of the gall-bladder: an experience and review of the literature. Aust N Z J Surg. 1995;65:724–727
  132. Ouchi K, Mikuni J, Kakugawa Y. Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients. J Hepatobiliary Pancreat Surg. 2002;9:256–260
  133. Weiland ST, Mahvi DM, Niederhuber JE, et al. Should suspected early gallbladder cancer be treated laparoscopically?. J Gastrointest Surg. 2002;6:50–56discussion 56-7
  134. Wibbenmeyer LA, Wade TP, Chen RC, et al. Laparoscopic cholecystectomy can disseminate in situ carcinoma of the gallbladder. J Am Coll Surg. 1995;181:504–510
  135. Wakai T, Shirai Y, Hatakeyama K. Radical second resection provides survival benefit for patients with T2 gallbladder carcinoma first discovered after laparoscopic cholecystectomy. World J Surg. 2002;26:867–871Epub 2002 Apr 18
  136. Suzuki K, Kimura T, Ogawa H. Is laparoscopic cholecystectomy hazardous for gallbladder cancer?. Surgery. 1998;123:311–314
  137. Ogura Y, Mizumoto R, Isaji S, et al. Radical operations for carcinoma of the gallbladder: present status in Japan. World J Surg. 1991;15:337–343
  138. Toyonaga T, Chijiiwa K, Nakano K, et al. Completion radical surgery after cholecystectomy for accidentally undiagnosed gallbladder carcinoma. World J Surg. 2003;27:266–271
  139. Shirai Y, Yoshida K, Tsukada K, et al. Early carcinoma of the gallbladder. Eur J Surg. 1992;158:545–548
  140. Taner CB, Nagorney DM, Donohue JH. Surgical treatment of gallbladder cancer. J Gastrointest Surg. 2004;8:83–89discussion 89
  141. Wagholikar GD, Behari A, Krishnani N, et al. Early gallbladder cancer. J Am Coll Surg. 2002;194:137–141
  142. Ouchi K, Suzuki M, Tominaga T, et al. Survival after surgery for cancer of the gallbladder. Br J Surg. 1994;81:1655–1657
  143. Matsumoto Y, Fujii H, Aoyama H, et al. Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am J Surg. 1992;163:239–245
  144. Wakai T, Shirai Y, Yokoyama N, et al. Early gallbladder carcinoma does not warrant radical resection. Br J Surg. 2001;88:675–678
  145. Bartlett DL. Gallbladder cancer. Semin Surg Oncol. 2000;19:145–155
  146. Fong Y, Heffernan N, Blumgart LH. Gallbladder carcinoma discovered during laparoscopic cholecystectomy: aggressive reresection is beneficial. Cancer. 1998;83:423–427
  147. Shirai Y, Yoshida K, Tsukada K, et al. Radical surgery for gallbladder carcinoma (Long-term results). Ann Surg. 1992;216:565–568
  148. Bartlett DL, Fong Y, Fortner JG, et al. Long-term results after resection for gallbladder cancer (Implications for staging and management). Ann Surg. 1996;224:639–646
  149. de Aretxabala X, Roa I, Burgos L, et al. Gallbladder cancer in Chile (A report on 54 potentially resectable tumors). Cancer. 1992;69:60–65
  150. de Aretxabala XA, Roa IS, Burgos LA, et al. Curative resection in potentially resectable tumours of the gallbladder. Eur J Surg. 1997;163:419–426
  151. Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg. 2000;232:557–569
  152. Suzuki S, Yokoi Y, Kurachi K, et al. Appraisal of surgical treatment for pT2 gallbladder carcinomas. World J Surg. 2004;28:160–165
  153. Paolucci V, Neckell M, Gotze T. [Unsuspected gallbladder carcinoma—the CAE-S/CAMIC registry]. Zentralbl Chir. 2003;128:309–312
  154. Suzuki K, Kimura T, Ogawa H, et al. Long-term prognosis of gallbladder cancer diagnosed after laparoscopic cholecystectomy port site recurrence of gallbladder cancer after laparoscopic surgery: two case reports of long-term survival. Is laparoscopic cholecystectomy hazardous for gallbladder cancer? (Surg Endosc). 2000;14:712–716
  155. Muratore A, Amisano M, Vigano L, et al. Gallbladder cancer invading the perimuscular connective tissue: results of reresection after prior non-curative operation. J Surg Oncol. 2003;83:212–215
  156. Bouvy ND, Marquet RL, Jeekel H, Bonjer HJ. Impact of gas(less) laparoscopy and laparotomy on peritoneal tumor growth and abdominal wall metastases. Ann Surg. 1996;224:694–700discussion 700-1
  157. Aoki Y, Shimura H, Li H, et al. A model of port-site metastases of gallbladder cancer: the influence of peritoneal injury and its repair on abdominal wall metastases. Surgery. 1999;125:553–559
  158. Schaeff B, Paolucci V, Thomopoulos J. Port site recurrences after laparoscopic surgery (A review). Dig Surg. 1998;15:124–134
  159. Paolucci V, Schaeff B, Schneider M, Gutt C. Tumor seeding following laparoscopy: international survey. [see comment] World J Surg. 1999;23:989–995discussion 996-7
  160. Paolucci V. Port site recurrences after laparoscopic cholecystectomy. J Hepatobiliary Pancreat Surg. 2001;8:535–543
  161. Lundberg O, Kristoffersson A. Port site metastases from gallbladder cancer after laparoscopic cholecystectomy (Results of a Swedish survey and review of published reports). Eur J Surg. 1999;165:215–222
  162. Lundberg O, Kristoffersson A. Wound recurrence from gallbladder cancer after open cholecystectomy. Surgery. 2000;127:296–300
  163. Sarli L, Contini S, Sansebastiano G, et al. Does laparoscopic cholecystectomy worsen the prognosis of unsuspected gallbladder cancer?. Arch Surg. 2000;135:1340–1344
  164. Nimura Y, Hayakawa N, Kamiya J, et al. Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepatogastroenterology. 1991;38:170–175
  165. Yamaguchi K, Chijiiwa K, Shimizu S, et al. Anatomical limit of extended cholecystectomy for gallbladder carcinoma involving the neck of the gallbladder. Int Surg. 1998;83:21–23
  166. Ogura Y, Tabata M, Kawarada Y, Mizumoto R. Effect of hepatic invasion on the choice of hepatic resection for advanced carcinoma of the gallbladder: histologic analysis of 32 surgical cases. World J Surg. 1998;22:262–266discussion 266-7
  167. Shimizu Y, Ohtsuka M, Ito H, et al. Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer?. Surgery. 2004;136:1012–1017discussion 1018
  168. Kaneoka Y, Yamaguchi A, Isogai M, et al. Hepatoduodenal ligament invasion by gallbladder carcinoma: histologic patterns and surgical recommendation. World J Surg. 2003;27:260–265
  169. Nakamura S, Sakaguchi S, Suzuki S, Muro H. Aggressive surgery for carcinoma of the gallbladder. Surgery. 1989;106:467–473
  170. Nakamura S, Nishiyama R, Yokoi Y, et al. Hepatopancreatoduodenectomy for advanced gallbladder carcinoma. Arch Surg. 1994;129:625–629
  171. Todoroki T, Takahashi H, Koike N, et al. Outcomes of aggressive treatment of stage IV gallbladder cancer and predictors of survival. Hepatogastroenterology. 1999;46:2114–2121
  172. Kondo S, Nimura Y, Hayakawa N, et al. Extensive surgery for carcinoma of the gallbladder. Br J Surg. 2002;89:179–184
  173. Chijiiwa K, Tanaka M. Carcinoma of the gallbladder: an appraisal of surgical resection. Surgery. 1994;115:751–756
  174. Shirai Y, Ohtani T, Tsukada K, Hatakeyama K. Combined pancreaticoduodenectomy and hepatectomy for patients with locally advanced gallbladder carcinoma: long term results. Cancer. 1997;80:1904–1909
  175. Todoroki T, Kawamoto T, Takahashi H, et al. Treatment of gallbladder cancer by radical resection. [see comment] Br J Surg. 1999;86:622–627
  176. Sasaki R, Itabashi H, Fujita T, et al. Significance of extensive surgery including resection of the pancreas head for the treatment of gallbladder cancer—from the perspective of mode of lymph node involvement and surgical outcome. World J Surg. 2006;30:36–42
  177. Dixon E, Vollmer CM, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American center. Ann Surg. 2005;241:385–394
  178. Doty JR, Cameron JL, Yeo CJ, et al. Cholecystectomy, liver resection, and pylorus-preserving pancreaticoduodenectomy for gallbladder cancer: report of five cases. J Gastrointest Surg. 2002;6:776–780
  179. Cameron JL, Pitt HA, Zinner MJ, et al. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg. 1990;159:91–97discussion 97-8
  180. Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis. 1994;14:109–114
  181. Parikh AA, Abdalla EK, Vauthey JN. Operative considerations in resection of hilar cholangiocarcinoma. HPB. 2005;7:254–258
  182. Mansfield SD, Barakat O, Charnley RM, et al. Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome. World J Gastroenterol. 2005;11:7625–7630
  183. Launois B, Terblanche J, Lakehal M, et al. Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg. 1999;230:266–275
  184. Weber SM, DeMatteo RP, Fong Y, et al. Staging laparoscopy in patients with extrahepatic biliary carcinoma (Analysis of 100 patients). Ann Surg. 2002;235:392–399
  185. Gerhards MF, van Gulik TM, de Wit LT, et al. Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma—a single center experience. Surgery. 2000;127:395–404
  186. Nishio H, Nagino M, Nimura Y. Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB. 2005;7:259–262
  187. Nimura Y, Hayakawa N, Kamiya J, et al. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990;14:535–543discussion 544
  188. Ogura Y, Mizumoto R, Tabata M, et al. Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas. World J Surg. 1993;17:85–92discussion 92-3
  189. Dinant S, Gerhards MF, Rauws EA, et al. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol. 2006;13:872–880
  190. Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238:720–727
  191. Hemming AW, Kim RD, Mekeel KL, et al. Portal vein resection for hilar cholangiocarcinoma. Am Surg. 2006;72:599–604discussion 604-5
  192. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999;230:808–818discussion 819
  193. Smith RC, Pooley M, George CR, Faithful GR. Preoperative percutaneous transhepatic internal drainage in obstructive jaundice: a randomized, controlled trial examining renal function. Surgery. 1985;97:641–648
  194. Wig JD, Kumar H, Suri S, Gupta NM. Usefulness of percutaneous transhepatic biliary drainage in patients with surgical jaundice–a prospective randomised study. J Assoc Phys India. 1999;47:271–274
  195. Hatfield AR, Tobias R, Terblanche J, et al. Preoperative external biliary drainage in obstructive jaundice (A prospective controlled clinical trial). Lancet. 1982;2:896–899
  196. McPherson GA, Benjamin IS, Hodgson HJ, et al. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg. 1984;71:371–375
  197. Iwatsuki S, Todo S, Marsh JW, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg. 1998;187:358–364
  198. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation. 2000;69:1633–1637
  199. Robles R, Figueras J, Turrion VS, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg. 2004;239:265–271
  200. Shimoda M, Farmer DG, Colquhoun SD, et al. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transplant. 2001;7:1023–1033
  201. Zheng SS, Huang DS, Wang WL, et al. Orthotopic liver transplantation in treatment of 77 patients with end-stage hepatic disease. Hepatobiliary Pancreat Dis Int. 2002;1:8–13
  202. Cherqui D, Alon R, Piedbois P, et al. Combined liver transplantation and pancreatoduodenectomy for irresectable hilar bile duct carcinoma. Br J Surg. 1995;82:397–398
  203. Jonas S, Kling N, Guckelberger O, et al. Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma (First long-terms results). Transpl Int. 1998;11(Suppl 1):S206–S208
  204. Anthuber M, Schauer R, Jauch KW, et al. [Experiences with liver transplantation and liver transplantation combined with Whipple’s operation in Klatskin tumor]. Langenbecks Arch Chir Suppl Kongressbd. 1996;113:413–415
  205. Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242:451–458discussion 458-61
  206. Sotiropoulos GC, Lang H, Niebel W, et al. 10-year tumor-free survival after intraoperative radiation therapy and secondary liver transplantation for hilar cholangiocarcinoma. Transplantation. 2004;77:1625
  207. Sudan D, DeRoover A, Chinnakotla S, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant. 2002;2:774–779
  208. Oertli D, Herzog U, Tondelli P. Primary carcinoma of the gallbladder: operative experience during a 16 year period. Eur J Surg. 1993;159:415–420
  209. Alexander F, Rossi RL, O’Bryan M, et al. Biliary carcinoma (A review of 109 cases). Am J Surg. 1984;147:503–509
  210. Wade TP, Prasad CN, Virgo KS, Johnson FE. Experience with distal bile duct cancers in U.S. Veterans Affairs hospitals: 1987-1991. J Surg Oncol. 1997;64:242–245
  211. de Groen PC, Gores GJ, LaRusso NF, et al. Biliary tract cancers. N Engl J Med. 1999;341:1368–1378
  212. Falkson G, MacIntyre JM, Moertel CG. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer. 1984;54:965–969
  213. Takada T, Kato H, Matsushiro T, et al. Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas. Oncology. 1994;51:396–400
  214. Kajanti M, Pyrhonen S. Epirubicin-sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system (A phase II study). Am J Clin Oncol. 1994;17:223–226
  215. Glimelius B, Hoffman K, Sjoden PO, et al. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol. 1996;7:593–600
  216. Reyes-Vidal J, Gallardo J, Yanez E. Gemcitabine and cisplatin in the treatment of patients with unresectable or metastatic gallbladder cancer: results of the phase II Gocchi study 2000-13. Proc Am Soc Clin Oncol. 2003;22
  217. Doval DC, Sekhon JS, Gupta SK, et al. A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer. 2004;90:1516–1520
  218. Taieb J, Mitry E, Boige V, et al. Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma. Ann Oncol. 2002;13:1192–1196
  219. Mitry E, Van Cutsem E, Van Laethem J. A randomized phase II trial of weekly high dose 5-FU (HD-FU) with and without folinic acid (FA) and cisplatin (P) in patients with advanced biliary tract carcinoma: the EORTC 40955 trial. Proc Am Soc Clin Oncol. 2002;22:175
  220. Patt YZ, Hassan MM, Lozano RD, et al. Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer. Clin Cancer Res. 2001;7:3375–3380
  221. Rao S, Cunningham D, Hawkins RE, et al. Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer. Br J Cancer. 2005;92:1650–1654
  222. Gallardo JO, Rubio B, Fodor M, et al. A phase II study of gemcitabine in gallbladder carcinoma. Ann Oncol. 2001;12:1403–1406
  223. Kubicka S, Rudolph KL, Tietze MK, et al. Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Hepatogastroenterology. 2001;48:783–789
  224. Penz M, Kornek GV, Raderer M, et al. Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol. 2001;12:183–186
  225. Raderer M, Hejna MH, Valencak JB, et al. Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer. Oncology. 1999;56:177–180
  226. Gebbia V, Giuliani F, Maiello E, et al. Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol. 2001;19:4089–4091
  227. Hsu C, Shen YC, Yang CH, et al. Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract. Br J Cancer. 2004;90:1715–1719
  228. Knox JJ, Hedley D, Oza A, et al. Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience. Ann Oncol. 2004;15:770–774
  229. Knox JJ, Hedley D, Oza A, et al. Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol. 2005;23:2332–2338
  230. Townsley C, Knox J. An expanded phase II study combining gemcitabine and capecitabine in patients with advanced biliary cancer (International Society of Gastrointestinal Oncology (ISGIO) 2nd Annual Conference). Virginia: Arlington; 2005;
  231. Cho JY, Paik YH, Chang YS, et al. Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. Cancer. 2005;104:2753–2758
  232. Kuhn R, Hribaschek A, Eichelmann K, et al. Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas. Invest New Drugs. 2002;20:351–356
  233. Andre T, Tournigand C, Rosmorduc O, et al. Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol. 2004;15:1339–1343
  234. Andre T, Reyes-Vidal J, Fartoux L. EXIBIT: an international multicenter phase II trial of gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary cancer. Proc Am Soc Clin Oncol. 2006;26
  235. Iyer RV, Gibbs DL, Soehnlein N. Aphase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and gallbladder carcinoma. Proc Am Soc Clin Oncol. 2005;23
  236. Valle JW, Wasan H, Johnson P. Gemcitabine, alone or in combination with cisplatin, in patients with advanced or metastatic cholangiocarcinoma and other biliary tract tumors: A multicenter, randomized phase II (the UK ABC-01) study. Proc Am Soc Clin Oncol. 2006;24
  237. Lozano RD, Patt YZ, Hassan MM. Oral capecitabine (Xeloda) for the treatment of hepatobiliary cancers (hepatocellular carcinoma, cholangiocarcinoma and gallbladder cancer). Proc Am Soc Clin Oncol. 2000;19:264a
  238. Kornek GV, Schuell B, Laengle F, et al. Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. Ann Oncol. 2004;15:478–483
  239. Nehls O, Oettle H, Hartmann J-T. Multicenter phase II trial of oxaliplatin plus capecitabine (XELOX) in advanced biliary system adenocarcinomas (study CCC/GBC-01). Proc Am Soc Clin Oncol. 2003;22
  240. Sanz-Altamira PM, Ferrante K, Jenkins RL, et al. A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma. Cancer. 1998;82:2321–2325
  241. Hess V, Salzberg M, Borner M, et al. Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial. J Clin Oncol. 2003;21:66–68
  242. Hidalgo M, Castellano D, Paz-Ares L, et al. Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer. J Clin Oncol. 1999;17:585–592
  243. Schulz L, Schalhorn W, Wilmanns W. Synergistic interaction of gemcitabine and 5-fluorouracil in colon cancer cells. Proc Am Soc Clin Oncol. 1998;17:251a
  244. Sawada N, Fujimoto-Ouchi K, Ishikawa T. Antitumor activity of combination therapy with capecitabine plus vinorelbine, and capecitabine plus gemcitabine in human tumor xenograft models. Proc Am Assoc Cancer Res. 2002;
  245. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors (European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada). J Natl Cancer Inst. 2000;92:205–216
  246. Philip PA, Mahoney MR, Allmer C, et al. Phase II study of erlotinib in patients with advanced biliary cancer. J Clin Oncol. 2006;24:3069–3074
  247. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322:352–358
  248. Takada T, Amano H, Yasuda H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? (A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma). Cancer. 2002;95:1685–1695
  249. McMasters KM, Tuttle TM, Leach SD, et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg. 1997;174:605–608discussion 608-9
  250. Gierga DP, Chen GT, Kung JH, et al. Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions. Int J Radiat Oncol Biol Phys. 2004;58:1584–1595
  251. Dawson LA, Normolle D, Balter JM, et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002;53:810–821
  252. Hawkins M, Dawson L. From palliation to cure: radiotherapy for hepatocellular carcinoma. Cancer. 2006;106(8):1653–1663
  253. Vaittenim E. Carcinoma of the gallbladder. Ann Chir Gynaecol. 1970;168:1
  254. Kresl JJ, Schild SE, Henning GT, et al. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys. 2002;52:167–175
  255. Morrow C, Sutherland D, Florack G. Primary gallbladder carcinoma: significance of subserosal lesions and results of aggressive surgical treatment and adjuvant chemotherapy. Surgery. 1983;94:709
  256. Smoron GL. Radiation therapy of carcinoma of gallbladder and biliary tract. Cancer. 1977;40:1422–1424
  257. Czito BG, Hurwitz HI, Clough RW, et al. Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys. 2005;62:1030–1034
  258. Houry S, Schlienger M, Huguier M, et al. Gallbladder carcinoma: role of radiation therapy. Br J Surg. 1989;76:448–450
  259. Albores-Saavedra J, Molberg K, Henson DE. Unusual malignant epithelial tumors of the gallbladder. Semin Diagn Pathol. 1996;13:326–338
  260. Sugimoto K, Ohzato H, Tomita N, et al. [Two cases of successful local control with intermittent hepatic arterial infusion therapy using 5-FU and external radiation therapy for unresectable advanced gall bladder cancer]. Gan to Kagaku Ryoho. 2005;32:1855–1858[Japanese Journal of Cancer & Chemotherapy]
  261. Montemaggi P, Morganti AG, Dobelbower RR, et al. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation?. Radiology. 1996;199:861–866
  262. Kopelson G, Galdabini J, Warshaw AL, Gunderson LL. Patterns of failure after curative surgery for extra-hepatic biliary tract carcinoma: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys. 1981;7:413–417
  263. Lim JH, Park CK. Pathology of cholangiocarcinoma. Abdom Imaging. 2004;29:540–547
  264. Chang HJ, Jee CD, Kim WH. Mutation and altered expression of beta-catenin during gallbladder carcinogenesis. Am J Surg Pathol. 2002;26:758–766
  265. Morganti AG, Trodella L, Valentini V, et al. Concomitant gemcitabine (Gemzar) and extended nodes irradiation in the treatment of pancreatic and biliary carcinoma: a phase I study. Onkologie. 2003;26:325–329
  266. Todoroki T, Ohara K, Kawamoto T, et al. Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys. 2000;46:581–587
  267. Kurosaki H, Karasawa K, Kaizu T, et al. Intraoperative radiotherapy for resectable extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys. 1999;45:635–638
  268. Pitt HA, Nakeeb A, Abrams RA, et al. Perihilar cholangiocarcinoma (Postoperative radiotherapy does not improve survival). Ann Surg. 1995;221:788–797discussion 797-8
  269. Lillemore KD, Cameron JL. Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach. J Hepatobiliary Pancreat Surg. 2000;7:115–121
  270. Zlotecki RA, Jung LA, Vauthry JN, et al. Carcinoma of the extrahepatic biliary tract: Surgery and radiotherapy for curative and palliatve intent. Radio Oncol Invest. 1998;6:240–247
  271. Gonzalez D, Gerard J, Maners A, et al. Results of radiation therapy in carcinoma a of the proximal bile duct (Klatskin tumor). Semin Liver Dis. 1990;10:131
  272. Grove MK, Hermann RE, Vogt DP, Broughan TA. Role of radiation after operative palliation in cancer of the proximal bile ducts. Am J Surg. 1991;161:454–458
  273. Minsky BD, Wesson MF, Armstrong JG, et al. Combined modality therapy of extrahepatic biliary system cancer. Int J Radiat Oncol Biol Phys. 1990;18:1157–1163
  274. Fogel TD, Weissberg JB. The role of radiation therapy in carcinoma of the extrahepatic bile ducts. Int J Radiat Oncol Biol Phys. 1984;10:2251–2258
  275. Veeze-Kuijpers B, Meerwaldt JH, Lameris JS, et al. The role of radiotherapy in the treatment of bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1990;1:63–67
  276. Fritz P, Brambs HJ, Schraube P, et al. Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas. Int J Radiat Oncol Biol Phys. 1994;29:855–861
  277. Alden ME, Mohiuddin M. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys. 1994;28:945–951
  278. Kopelson G, Harisiadis L, Tretter P, Chang CH. The role of radiation therapy in cancer of the extra-hepatic biliary system: an analysis of thirteen patients and a review of the literature of the effectiveness of surgery, chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys. 1977;2(9-10):883–894
  279. Monson JR, Donohue JH, Gunderson LL, et al. Intraoperative radiotherapy for unresectable cholangiocarcinoma–the Mayo Clinic experience. Surg Oncol. 1992;1:283–290
  280. Shin H, Seong J, Kim W, et al. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts. Int J Radiat Oncol Biol Phys. 2003;57
  281. Foo M, Gunderson L, Bender C, et al. External radiation therapy in carcinoma of the extrahepatic bile ducts. Int J Radiat Oncol Biol Phys. 1984;10:2251
  282. Flickinger JC, Epstein AH, Iwatsuki S, et al. Radiation therapy for primary carcinoma of the extrahepatic biliary system (An analysis of 63 cases). Cancer. 1991;68:289–294
  283. Crane C, Macdonald K, Vauthey J, et al. Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol Biol Phys. 2002;53:969
  284. Morganti AG, Trodella L, Valentini V, et al. Combined modality treatment in unresectable extrahepatic biliary carcinoma. Int J Radiat Oncol Biol Phys. 2000;46:913–919
  285. Park JY, Park SW, Chung JB, et al. Concurrent chemoradiotherapy with doxifluridine and paclitaxel for extrahepatic bile duct cancer. Am J Clin Oncol. 2006;29:240–245
  286. Hayes JK, Sapozink MD, Miller FJ. Definitive radiation therapy in bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1988;15:735–744
  287. Sicklick JK, Choti MA. Controversies in the surgical management of cholangiocarcinoma and gallbladder cancer. Semin Oncol. 2005;32(6 Suppl 9):S112–S117
  288. Chijiiwa K, Nakano K, Ueda J, et al. Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer. J Am Coll Surg. 2001;192:600–607
  289. Su CH, Tsay SH, Wu CC, et al. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg. 1996;223:384–394
  290. Kosuge T, Yamamoto J, Shimada K, et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg. 1999;230:663–671
  291. Miyazaki M, Ito H, Nakagawa K, et al. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg. 1999;189:575–583
  292. Busse PM, Cady B, Bothe A, et al. Intraoperative radiation therapy for carcinoma of the gallbladder. World J Surg. 1991;15:352–356

PII: S0011-3840(07)00059-7

doi: 10.1067/j.cpsurg.2007.04.006

Current Problems in Surgery
Volume 44, Issue 7 , Pages 396-482 , July 2007

Article Tools

* Image Usage & Resolution